by GlobeNewsWire | Aug 19, 2016 | Globe Newswire
San Francisco, Aug. 19, 2016 (GLOBE NEWSWIRE) — The global therapeutic drug monitoring market is expected to reach over USD 3.37 billion by 2024, according to a new report by Grand View Research, Inc. Recent technological advancements in the Point-of-Care (PoC)...
by GlobeNewsWire | Aug 18, 2016 | Globe Newswire
REDWOOD CITY, Calif., Aug. 18, 2016 (GLOBE NEWSWIRE) — OncoMed Pharmaceuticals, Inc. (Nasdaq:OMED), a clinical-stage company developing novel anti-cancer stem cell and immuno-oncology therapeutics, today announced the pricing of an underwritten public offering...
by GlobeNewsWire | Aug 17, 2016 | Globe Newswire
COLUMBIA, Md., Aug. 17, 2016 (GLOBE NEWSWIRE) — Osiris Therapeutics, Inc. (NASDAQ:OSIR) (the “Company”) today provided an update regarding the status of its compliance with the Listing Rules of the NASDAQ Stock Market (“NASDAQ”). As previously disclosed, on each...
by GlobeNewsWire | Aug 17, 2016 | Globe Newswire
REDWOOD CITY, Calif., Aug. 17, 2016 (GLOBE NEWSWIRE) — OncoMed Pharmaceuticals, Inc. (Nasdaq:OMED), a clinical-stage company developing novel anti-cancer stem cell and immuno-oncology therapeutics, today announced that it has commenced an underwritten public...
by GlobeNewsWire | Aug 16, 2016 | Globe Newswire
CARLSBAD, Calif., Aug. 16, 2016 (GLOBE NEWSWIRE) — International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) (“ISCO” or “the Company”), a California-based biotechnology company developing novel stem cell-based therapies and biomedical...